Quantum Computing Speeds Drug Development Time

Drug Development Speed

Quantum computing is increasingly being seen as a game-changer in the field of drug discovery. By accelerating the process of designing and testing new molecules, quantum computers have the potential to dramatically reduce the time and cost of bringing new drugs to market. In addition, quantum computers can help to screen for potential side effects and interactions with other drugs, making them an invaluable tool in the fight against life-threatening diseases. Quantum computing is thus playing a vital role in accelerating the development of new treatments and therapies, and saving lives in the process.

How AI Will Transform Drug Discovery

• Generate Biomedicines is a therapeutics company that uses artificial intelligence (AI) to accelerate the discovery of new drugs.
• Generate believes that AI will improve upon the current 90 percent failure rate for new drugs by helping to identify better targets, create safer molecules, and select patients more effectively.
• The lab of the future will be focused on generating data for algorithms so that they can constantly learn and improve.
• One challenge facing AI in medicine is creating data sets without bias; another is simply the complexity of human biology.

According to a 2020 study by the London School of Economics and Political Science, it usually takes about a decade to get a new drug to the market, and could cost as much as $1.3 billion.   Algorithmiq, a Finnish quantum startup said its novel approach could accelerate this process and help make new drugs that are "significantly" more efficient and less harmful using near-term quantum devices like those developed by IBM are expected to be enough to achieve progress in this area. "IBM believes the demonstration of quantum advantage in areas such as quantum chemistry is possible this decade," Ivano Tavernelli, IBM Research.